Send a Tweet
Most Popular Choices
Share on Facebook 9 Share on Twitter Printer Friendly Page More Sharing
Best Web OpEds   

How Pharma Companies Uses 'Citizen Petitions' to Keep Drug Prices High -

Quicklink Submitted By     (# of views)   No comments, 5 series
Author 40790
Follow Me on Twitter     Message Susan Lee Schwartz
Become a Fan
  (23 fans)

Anti-Competitive Agreements - iPleaders
Anti-Competitive Agreements - iPleaders
(Image by blog.ipleaders.in)
  Details   DMCA

Last year, brand-name pharma companies filed 92% of 505(q) citizen petitions, a specific type related to pending generic applications. And in turn, 92% of those petitions were ultimately rejected by the FDA. For its part, the FDA is is aware of a problem; the agency wrote it was concerned that current law “may not be discouraging the submissions that are intended primarily to delay the approval of competing drug products and do not raise valid scientific issues.” Gaming the FDA’s citizen petition this way puts the agency , whose  number one job is safety, in a tricky spot.  They’re not designed as a competition policing agency.” The scope of the problem, is bigger than the FDA and tricky. The issue sits at the junction of several areas of law that offer anticompetitive conduct.”: antitrust law, patent law, state drug etc.

Read the rest of the story HERE:

At www.theatlantic.com

 

Must Read 1  
Rate It | View Ratings

Susan Lee Schwartz Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

I began teaching in 1963,; Ba and BS in Education -Brooklyn College. I have the equivalent of 2 additional Master's, mainly in Literacy Studies and Graphic Design. I was the only seventh grade teacher of English from 1990 -1999 at East Side (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

Other Series: View All 173 Articles in "WEALTH"

Other Series: View All 455 Articles in "wrecking Ball"